Study of the Use of a Single Dose of Erythropoietin to Treat Acute Myocardial Ischemia

NCT00524901 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

CABG
Coronary Artery Disease

Interventions

DRUG: Epoetin alpha
DRUG: NaCl 0.9%

Sponsor

University Medical Center Groningen